1. Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis
    Yuan Tian et al, 2016, Cancers CrossRef
  2. Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors.
    Carolina Méndez-Blanco et al, 2018, Exp Mol Med CrossRef
  3. Enhanced angiogenesis, hypoxia and neutrophil recruitment during Myc-induced liver tumorigenesis in zebrafish
    Ye Zhao et al, 2016, Sci Rep CrossRef
  4. Advances in Hypoxia-Mediated Mechanisms in Hepatocellular Carcinoma
    Xin Xin Xiong et al, 2017, Mol Pharmacol CrossRef
  5. Hypoxia-inducible factors as molecular targets for liver diseases.
    Cynthia Ju et al, 2016, J Mol Med (Berl) CrossRef
  6. c-Myc promotes tumor proliferation and anti-apoptosis by repressing p21 in rhabdomyosarcomas
    Jinghang Zhang et al, 2017 CrossRef
  7. A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib
    David G. Covell et al, 2017, PLoS ONE CrossRef
  8. New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies.
    Leilei Niu et al, 2017, Biochim Biophys Acta Rev Cancer CrossRef
  9. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells
    Carolina Méndez-Blanco et al, 2019, Cancers CrossRef
  10. Hypoxia inducible factors in hepatocellular carcinoma.
    Chu Chen et al, 2017, Oncotarget CrossRef
  11. Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient protocatechualdehyde
    Ning Wang et al, 2017, Oncotarget CrossRef

  12. Hypoxia-Induced Aquaporin-3 Changes Hepatocellular Carcinoma Cell Sensitivity to Sorafenib by Activating the PI3K/Akt Signaling Pathway


    Kija Malale et al, 2020, CMAR CrossRef
  13. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects.
    Weiwei Tang et al, 2020, Signal Transduct Target Ther CrossRef
  14. microRNA-223 promotes autophagy to aggravate lung ischemia-reperfusion injury by inhibiting the expression of transcription factor HIF2α
    Chunlin Ye et al, 2020, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
  15. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
    Monica Mossenta et al, 2020, Cancers CrossRef
  16. Molecular Bases of Drug Resistance in Hepatocellular Carcinoma.
    Jose J G Marin et al, 2020, Cancers (Basel) CrossRef
  17. Label-Free Quantitative Proteomics Analysis of the Sorafenib Resistance in HepG2 Cells
    Zi-Xuan Wang et al, 2021, J. Anal. Test. CrossRef
  18. Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
    Zhi Zeng et al, 2021, Front. Oncol. CrossRef
  19. Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems
    Jose J.G. Marin et al, 2021, Semin Liver Dis CrossRef
  20. Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation
    Beatrice Foglia et al, 2021, Cellular and Molecular Gastroenterology and Hepatology CrossRef
  21. Role of Alpha-Fetoprotein in Hepatocellular Carcinoma Drug Resistance
    Wei Li et al, 2021, CMC CrossRef
  22. Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
    Xinchen Tian et al, 2022, Front. Pharmacol. CrossRef
  23. Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
    Beiyuan Hu et al, 2022 CrossRef
  24. Resistance of Lenvatinib in Hepatocellular Carcinoma
    Jinhui Guo et al, 2022, CCDT CrossRef
  25. MYC in liver cancer: mechanisms and targeted therapy opportunities
    Furong Liu et al, 2023, Oncogene CrossRef
  26. Transplantation of Wnt3a-modified neural stem cells promotes neural regeneration and functional recovery after spinal cord injury via Wnt-Gli2 pathway
    Jiezhao Lin et al, 2023 CrossRef